Atlas Trials

Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas

Clinical trial NCT05937776 · COMPLETED

Trial details

NCT number
NCT05937776
Sponsor
OHSU Knight Cancer Institute
Status
COMPLETED
Study type
OBSERVATIONAL
Glioma
Start date
2023-12-11
Primary completion
2025-12-31
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.